Alnylam, Medtronic & CHDI form RNAi delivery collaboration
Alnylam Pharmaceuticals, Medtronic and CHDI Foundation are collaborating to advance RNAi delivered by an implantable infusion device for treating Huntingdon’s.
Archives for November 8, 2010
Appointments at Parexel, Catalent, AMRI, BioStorage and BRANY – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Parexel, Catalent, AMRI, BioStorage and BRANY.
Endo's takeover of Penwest gets shareholder approval
Penwest Pharmaceuticals shareholders have voted in favour of Endo Pharmaceuticals takeover plan, paving the way for the $144m merger.
Novartis and Arabio enter Swiss-Saudi vax manufacturing partnership
Novartis is teaming up with Arab Company for Pharmaceutical Products (Arabio) to provide Saudi Arabia and surrounding regions with vaccines for common diseases.
Alleged scientific misconduct in Russian Afrezza trial
An ex-employee has alleged that “scientific misconduct” took place during trials of MannKind’s candidate inhalable diabetes drug Afrezza.
Celanese rolls out new customisable EVA excipient
Celanese has launched a new controlled-release EVA excipient and says developing enhanced formulations is key to a drugmaker’s competitive edge in today’s pharmaceutical market.
Synteract adding 30 staff at expanded RTP, NC site
Synteract is to hire up to 30 additional staff by the end of 2011 to work at its recently expanded site in Research Triangle Park (RTP), North Carolina, US.